On November 17th, 2008 was the opening of a new pharmaceutical facility at Tathimpharmpreparaty (Kazan). Plant for production of solid dosage forms (capsules and tablets) in compliance with the requirements of European standard GMP was built in partnership with a Czech engineering c...
17 ноября на заводе Татхимфармпрепараты (город Казань) состоялось открытие нового фармацевтического производства. Цех по выпуску твердых лекарственных форм (таблетированных и капсулированных) в соответствии с требованиями европейского стандарта GMP построен в партнерстве с чешской инжиниринговой компанией FAVEA engineering, специализирующейся на реконструкции фармацевтических производств.
Проектирование и строительства цеха велось в течение двух лет. Мощности нового производства составят 1,5 млрд. таблеток (из них до 50 процентов таблеток, покрытые оболочкой) и 250 млн. капсул в год, что делает его одним из крупнейших среди аналогичных производств в России.
Предприятие ОАО "Татхимфармпрепараты" планируется нарастить объемы производства продукции с нынешнего 1 миллиарда рублей до полутора миллиардов в 2009 году. В строительство нового производства по выпуску таблетированных препаратов было инвестировано около 15 млн. евро, в том числе 10,2 млн. евро – заемные средства. Финансирование строительства осуществлялось за счет экспортного кредита со сроком погашения семь лет. Кредит был получен с помощью компании FAVEA engineering у чешского Komercni Bank. Срок окупаемости производства – около трех лет.
Has been awarded the GMP certificate which entitles the company to produce humane and veterinary pharmaceuticals. Our production activities focus on production of nutritional supplements, cosmetics and also on production and sales of food products and cosmetic substances.
FAVEA - one of the leading engineering companies in the realization of new pharmaceutical projects and in renovation of existing ones. Since 1992, FAVEA develop and realize pharmaceutical projects such as building clean rooms, air conditioning and ventilation systems, supplies equipment, launching the production line, validation and certification of the new objects in compliance with GMP. Among our clients are such famous companies as «Nizhpharm», «Pharmstandard», «Tathimpharmpreparaty», «Soteks», BHFZ, Darnitsa etc.
Our projects
Production in compliance with GMP
The basic profile of FAVEA – realization of the new pharmaceutical facilities and reconstruction of existing ones in compliance with GMP. The main objects for reconstruction are:
Pharmaceutical and biotechnological companies;
Medical centers and health care facilities;
Medical equipment producers.
The quality of FAVEA
Compliance with the current production standard of GMP
Wherever FAVEA realized projects on construction and reconstruction, Customer has successfully passed the national and international audit, received certificates which confirm the compliance with the current production standard of GMP.
Customers appreciate the quality of work done by FAVEA in numerous reviews.
Futures of FAVEA
Realization of «turnkey» projects
The main features of our company are:
Professional team of highly qualified engineers,
Own training center and a large experience in organization of the training,
Featured long-term export financing of projects by Czech banks,
Realization of the «turnkey» projects.
Our Training Center
Seminars and applied trainings
FAVEA conducts seminars and applied trainings in its own Production and Training Center for the qualified personnel of our Customers on the following key themes:
Terms of GMP;
New production process for different dosage forms;
Clean-rooms equipment;
Validation.
This year “Platinum Ounce” award in the special category of the organizing committee for the “Successful implementation of projects on modernization of pharmaceutical production in Russian Federation in accordance with the standards GMP” received company FAVEA
Video
Opening of a new pharmaceutical production in Kazan
The new production of growth hormone RASTAN in Ufa
Photos
Kazan, plant for tablets production, 2007 - 2008
Tomsk, reconstruction of pharmaceutical production - 2008
The worldwide most important document in determining the requirements for production and quality control of medicines for humans and animals is "Good Manufacturing Practice for Medicinal Products (GMP)".
Validation
In the methodological guidance we take into account the most recent issues of the national normative documents, the recommendations of the World Health Organization (WHO) and the Convention on mutual recognition of inspections in ...
GMP Training
The purpose of this training is to deepen the fundamental knowledge and expertise on the development of modern pharmaceuticals, manufacturing and quality control. Important objective is to train the personnel, ...